<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-49-551C77">
 <label>77</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Teixeira</surname>, 
    <given-names>F.R.</given-names>
   </string-name>, 
   <string-name>
    <surname>Randle</surname>, 
    <given-names>S.J.</given-names>
   </string-name>, 
   <string-name>
    <surname>Patel</surname>, 
    <given-names>S.P.</given-names>
   </string-name>, 
   <string-name>
    <surname>Mevissen</surname>, 
    <given-names>T.E.T.</given-names>
   </string-name>, 
   <string-name>
    <surname>Zenkeviciute</surname>, 
    <given-names>G.</given-names>
   </string-name>, 
   <string-name>
    <surname>Koide</surname>, 
    <given-names>T.</given-names>
   </string-name>
   <etal>et al.</etal>
  </person-group> (
  <year>2016</year>) 
  <article-title>Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease</article-title>. 
  <source>Biochem. J.</source>
  <volume>473</volume>, 
  <fpage>3563</fpage>–
  <lpage>3580</lpage>
  <pub-id pub-id-type="doi">10.1042/BCJ20160387</pub-id>
  <pub-id pub-id-type="pmid">27503909</pub-id>
 </mixed-citation>
</ref>
